Barclays Boosts Bath & Body Works (NYSE:BBWI) Price Target to $32.00

Key Points

• Barclays has increased its price target for Bath & Body Works (NYSE:BBWI) from $30.00 to $32.00, suggesting an 8.60% potential upside from the current price.
• JPMorgan Chase raised its price target from $40.00 to $46.00, while Goldman Sachs adjusted theirs from $44.00 to $43.00, indicating strong analyst interest in the stock.
• Bath & Body Works announced a quarterly EPS of $0.37, aligning with market estimates, as the company projects FY 2025 EPS between $3.350-3.600.

Bath & Body Works (NYSE:BBWI - Get Free Report) had its price target increased by equities researchers at Barclays from $30.00 to $32.00 in a report released on Friday,Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Barclays's price target indicates a potential upside of 8.60% from the company's current price.

Several other research firms have also recently weighed in on BBWI. JPMorgan Chase & Co. increased their price objective on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research report on Monday, July 28th. Morgan Stanley reduced their price target on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. The Goldman Sachs Group reduced their target price on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Finally, Telsey Advisory Group reiterated an "outperform" rating and issued a $38.00 target price on shares of Bath & Body Works in a research note on Thursday. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $41.92.

Bath & Body Works Stock Performance

BBWI opened at $29.47 on Friday. The company has a market cap of $6.24 billion, a PE ratio of 7.86, a price-to-earnings-growth ratio of 1.06 and a beta of 1.54. The stock has a 50-day moving average of $30.61 and a 200-day moving average of $30.86. Bath & Body Works has a 52-week low of $24.94 and a 52-week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the prior year, the firm earned $0.37 EPS. Bath & Body Works's quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts predict that Bath & Body Works will post 3.3 earnings per share for the current year.

Hedge Funds Weigh In On Bath & Body Works

A number of institutional investors have recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC raised its position in shares of Bath & Body Works by 38.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock worth $1,265,000 after acquiring an additional 11,681 shares during the last quarter. Kovitz Investment Group Partners LLC bought a new stake in Bath & Body Works during the 4th quarter worth about $258,000. Merit Financial Group LLC bought a new stake in Bath & Body Works during the 1st quarter worth about $714,000. Nuveen Asset Management LLC raised its holdings in Bath & Body Works by 3.7% during the 4th quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after purchasing an additional 27,136 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its holdings in Bath & Body Works by 3,642.2% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after purchasing an additional 1,606,988 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.